Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis

To join this study, you would need to be an adult (18 years or older) with IgA vasculitis that has been confirmed by a special test called a biopsy. This is for people who have either just been diagnosed or are experiencing their condition flaring up again, especially if it's causing serious problems in at least one organ, like your kidneys or gut.

There are also some reasons why you wouldn't be able to join. For example, if you have another type of blood vessel inflammation, if your IgA vasculitis is already under control, or if you have severe heart problems or active infections. You also couldn't join if you've already had rituximab in the last year, or if you are pregnant, breastfeeding, or planning to become pregnant during the study period. Women who could become pregnant would need to use reliable contraception.

If you decide to take part, you would receive either the rituximab injection or a dummy treatment (placebo), alongside your usual steroid medication. The study will involve regular check-ups and assessments to monitor your condition and how you're responding to the treatment. This will include blood tests and other examinations to see if the medication is working and to check for any side effects. The total duration of the study and how many visits are required are not fully detailed here, but generally, clinical trials involve several visits over a period of many months, with follow-up appointments after the main treatment period.